Thus, we propose a model in which PARP9 induction during M. tuberculosis infection limits type I IFN, possibly via inhibition of a negative feedback loop, whereas during TB progression, PARP9 levels increase to modulate type I IFN signaling to limit M. tuberculosis susceptibility. This evidence concerns the gene PARP9 and tuberculosis.